Carregant...
Glycoform and Net Charge Heterogeneity in gp120 Immunogens Used in HIV Vaccine Trials
BACKGROUND: The RV144 clinical trial showed for the first time that vaccination could provide modest but significant protection from HIV-1 infection. To understand the protective response, and to improve upon the vaccine's efficacy, it is important to define the structure of the immunogens used...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3425498/ https://ncbi.nlm.nih.gov/pubmed/22928048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0043903 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|